NCP Domains 2, 3 & 5
Substance Use, Harm Reduction & Values
Recovery from substance use is deeply personal, and faith plays a real but time-limited role for many people. This page explains what the evidence shows about spirituality and recovery, the barriers faith communities can create or remove, and how abstinence-based and harm-reduction approaches compare, without taking a side.
Viewing as: Patient & Family · Change
Scope: spirituality's association with recovery outcomes, treatment-access barriers, harm-reduction and abstinence-based intervention outcomes, and chaplaincy's role in addiction care. Harm-reduction and abstinence-based approaches are presented side by side without a policy position. Islamic necessity (darura) guidance is named in prose only below, pending live verification.
Clinical evidence
A systematic review of 29 studies found at least some support for a beneficial relationship between spirituality/religion and substance-use recovery outcomes — abstinence, treatment retention, and use severity — across most studies reviewed.
A longitudinal study of 262 adults (95.4% Black/African American) found higher spiritual well-being predicted significantly less frequent substance use in early recovery (P=.03), and 12-step involvement predicted fewer consequences (P=.02) — but both effects diminished by 3.5-6.6 months post-treatment, a genuinely time-limited association.
A systematic narrative review of 24 studies found denial of problem severity, treatment-system mistrust, confidentiality fears, and stigma — not religiosity itself — were the recurring barriers to treatment and harm-reduction access in Muslim communities, recommending mosque engagement to reduce stigma.
A qualitative study of 8 religious and community leaders across 5 culturally-and-linguistically-diverse community groups in Sydney documented leaders playing both barrier and enabler roles in alcohol-and-other-drug treatment access — not solely gatekeepers of stigma.
A systematic review and meta-analysis of 49 studies found community naloxone distribution programs were associated with a 98.3% (95% CI 97.5-98.8) survival rate following administration in programs serving people who use drugs directly, sustained despite rising fentanyl-driven overdose rates.
A Campbell systematic review and meta-analysis of 48 papers, 34 studies, and 15,255 participants experiencing homelessness found both abstinence-based (-0.28 SD) and harm-reduction (0.03 SD) interventions had confidence intervals crossing zero versus treatment-as-usual — neither approach category showed a clear overall advantage, with individual interventions varying more than category.
A survey of 151 VA chaplains found many provide addiction care weekly with varying training and comfort levels, using foundational chaplaincy skills alongside occasional 12-step or motivational-interviewing approaches, and respondents wanted more evidence-based-modality training.
Islamic necessity (darura) guidance: pending live verification
A documented Islamic principle is named here in prose only, without formal citation, because our verification pipeline has not yet completed a live check of its source document: AMJA documents the darura (necessity) principle: substances otherwise forbidden by consensus may be used in medical treatment only under necessity or comparable need, under a trusted physician's supervision, when benefit is expected to outweigh harm and no permissible alternative exists. This is reported narrowly as a general necessity principle, potentially applicable to addiction pharmacotherapy, not as an addiction-specific ruling; no fatwa specifically addressing addiction pharmacotherapy by name was found. Per our methodology, a reference doesn't become a citation until it passes verification, including well-known ones.
Topics whose published claims share NCP domains with this page.